Symptomatic and cognitive effects of D-amino acid oxidase inhibitors in patients with schizophrenia: a meta-analysis of double-blind randomized controlled trials
Abstract D-amino acid oxidase inhibitors (DAOI) have demonstrated potential therapeutic benefits for schizophrenia and cognitive impairment; however, existing studies present conflicting results. This meta-analysis aimed to assess the symptomatic and cognitive effects of DAOI on the treatment of sch...
Saved in:
| Main Authors: | Chun-Hung Chang, Yu-Der Hsia, Wen-Chun Liu, Jia-Hau Lee, Chieh-Hsin Lin, Hsien-Yuan Lane |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Schizophrenia |
| Online Access: | https://doi.org/10.1038/s41537-025-00604-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acceptability and impact of computerised cognitive training on mental health and cognitive skills in schizophrenia: a double-blind controlled trial
by: Elahe Fathi Azar, et al.
Published: (2025-04-01) -
Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer’s disease: secondary analysis of a randomized clinical trial
by: Chieh-Hsin Lin, et al.
Published: (2025-08-01) -
Symptomatic Schizophrenia with Moya Moya Disease
by: Gerard McDade
Published: (1991-01-01) -
Exploring Cognitive Deficits and Neuromodulation in Schizophrenia: A Narrative Review
by: Chien-Chen Hung, et al.
Published: (2024-12-01) -
Theta-burst TMS in schizophrenia to ameliorate negative and cognitive symptoms: a double-blind, sham-controlled, randomized clinical trial
by: Boglarka Orban Szigeti
Published: (2025-01-01)